Mr Mrs Miss Ms Dr Other

Dr
Laurence
Gainey

Partner & European and UK Patent Attorney

Manchester Office Alderley Park Office

Life sciences

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 778 545 8684
Email. lgainey@hgf.com
Vcard
Linkedin

Experience

Laurence is a highly-experienced European and UK qualified patent attorney with over 25 years’ experience handling pharmaceutical and biotechnology subject matter. He has successfully managed patent portfolios on a variety of biotechnology subject matter, including diagnostic tools and targets, personalised healthcare (PHC), antisense oligonucleotide molecules, peptide and antibody (e.g. polyclonal, monoclonal, bispecific and conjugated) therapeutics, as well as handling the IP for small molecule discovery and high profile on sale pharmaceutical products, some with greater than $1bn annual sales.

After gaining a PhD in molecular biology from Reading University, Laurence joined a small biotechnology company to work in the laboratory on virus-based antigen delivery systems. After a couple of years, he moved internally to train as a patent attorney. In the same year as qualifying as European patent attorney Laurence joined the in-house patent department of AstraZeneca Pharmaceutical Ltd. where he worked for over 18 years before joining HGF’s Manchester office as a Patent Director in September 2017.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Cell and Molecular Biology

PHD

Molecular Biology - Reading University

POSTGRADUATE DIPLOMA OR CERTIFICATE

Certificate in Intellectual Property Law - Queen Mary University of London

Publications

Personalised drug patenting in Europe

View publication online

T0694/16 - New EPO Technical Board of Appeal decision regarding personalised healthcare inventions

View publication online

MBL Webinar entitled "Patent Due Diligence - The Fundamental Portfolio Checks Required"

View publication online

Chapter "Patent Considerations When Embarking on New Antisense Drug Programs" for the Open Access book "Antisense RNA Design, Delivery, and Analysis". "

View publication online

Conferences: 2022

27th June 2022

Webinar: A comparison of IP Practice in EU, US and JP for new medical use and method of treatment patenting

Speaker

Event details

Conferences: 2021

14th January 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2019

17th October 2019

Seminar: Strategies and updates on patenting inventions relating to personalised medicine in Europe and the US - Basel

Speaker

Event details

Related News

Event - 27th June 2022

Webinar: A comparison of IP Practice in EU, US and JP for new medical use and method of treatment patenting

HGF, Shiga and Wolf Greenfield and hosting a webinar to compare the IP Practice in EU, US and JP for new medical use and method of treatment patenting. Our expert …

Event details
Event - 14th January 2021

HGF IP in Healthcare Virtual Conference 2021

In 2021, HGF’s IP in Healthcare Conference will be delivered virtually through a series of webinars across January, February and March. The webinars will review the latest IP and related …

Event details
Event - 17th October 2019

Seminar: Strategies and updates on patenting inventions relating to personalised medicine in Europe and the US - Basel

HGF is hosting a seminar in Der Teufelhof Basel on Thursday 17th October at 6pm. Partner Dr Leena Contarino and Patent Director Dr Laurence Gainey will consider strategies for patenting inventions in Europe …

Event details
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us